Evolus, Inc. Common Stock · NASDAQ:EOLS
Medytox Inc.'s stake in Evolus, Inc. Common Stock fell to 3.40% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 6, 2025
Medytox Inc.'s stake in Evolus, Inc. Common Stock fell to 3.40%, 2,136,449 shares, as a passive investor on Dec 31, 2024. Filed Feb 6, 2025 (Schedule 13G/A).
- Stake
- 3.40%
- Shares
- 2,136,449
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Medytox Inc. | 3.40% | 2,136,449 |
Source
Related
- Evolus, Inc. Common Stock
- Medytox Inc.
- Evolus, Inc. Common Stock shareholders
- Form 4 · Moatazedi David · Sep 4, 2026
- Schedule 13G · Soleus Capital Master Fund, L.P. · Aug 31, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Timothy P. Lynch · Feb 17, 2026
- Schedule 13G/A · Tang Capital Management LLC · Feb 17, 2026